Samaritan Pharmaceuticals has announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels.
Source: http://www.news-medical.net/Pharmaceuticalnews.asp
Pharmaceutical News Feed